Literature DB >> 28844958

Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.

Naoki Tanaka1, Shogo Takahashi2, Xiao Hu3, Yu Lu3, Naoyuki Fujimori4, Srujana Golla2, Zhong-Ze Fang5, Toshifumi Aoyama3, Kristopher W Krausz2, Frank J Gonzalez6.   

Abstract

Growth arrest and DNA damage-inducible 45 α (Gadd45α) is a stress-inducible protein that plays an important role in cell survival/death and DNA repair, but its contribution to the development of nonalcoholic steatohepatitis (NASH) has not been investigated. C57BL/6 Gadd45a-null and wild-type (WT) mice were treated with a methionine and choline-deficient diet (MCD) for eight weeks and phenotypic changes examined. Gadd45a-null mice had more severe hepatic inflammation and fibrosis, higher levels of mRNAs encoding pro-inflammatory, pro-fibrotic, and pro-apoptotic proteins, and greater oxidative and endoplasmic reticulum (ER) stress compared with WT mice. Indeed, Gadd45a mRNA was induced in response to ER stress in primary hepatocytes. Lipidomic analysis of NASH livers demonstrated decreased triacylglycerol (TG) in MCD-treated Gadd45a-null mice, which was associated with increased mRNAs encoding phospholipase D (Pld1/2), phosphatidic acid phosphatase type 2A, and choline/ethanolamine phosphotransferase 1 (Cept1), involved in the phosphatidylcholine-phosphatidic acid-diacylglycerol cycle, and decreased mRNAs encoding fatty acid (FA)-binding protein 1 (Fabp1) and FA transport protein 5. Treatment of cultured primary hepatocytes with tumor necrosis factor α, transforming growth factor β, and hydrogen peroxide led to the corresponding induction of Fabp1, Pld1/2, and Cept1 mRNAs. Collectively, Gadd45α plays protective roles against MCD-induced NASH likely due to attenuating cellular stress and ensuing inflammatory signaling. These results also suggest an interconnection between hepatocyte injury, inflammation and disrupted glycerophospholipid/FA metabolism that yields a possible mechanism for decreased TG accumulation with NASH progression (i.e., "burned-out" NASH). Published by Elsevier B.V.

Entities:  

Keywords:  Burned-out NASH; ER stress; Glycerophospholipid metabolism; Lipidomics; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28844958      PMCID: PMC5675002          DOI: 10.1016/j.bbadis.2017.08.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  30 in total

1.  Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice.

Authors:  Aijuan Qu; Yatrik M Shah; Soumen K Manna; Frank J Gonzalez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-20       Impact factor: 8.311

2.  The molecular basis of leukocyte adhesion involving phosphatidic acid and phospholipase D.

Authors:  Francis Speranza; Madhu Mahankali; Karen M Henkels; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

3.  Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections.

Authors:  L C Junqueira; G Bignolas; R R Brentani
Journal:  Histochem J       Date:  1979-07

4.  Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.

Authors:  T Aoyama; S Yamano; D J Waxman; D P Lapenson; U A Meyer; V Fischer; R Tyndale; T Inaba; W Kalow; H V Gelboin
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

5.  Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.

Authors:  Michiharu Komatsu; Takefumi Kimura; Masahide Yazaki; Naoki Tanaka; Yang Yang; Takero Nakajima; Akira Horiuchi; Zhong-Ze Fang; Satoru Joshita; Akihiro Matsumoto; Takeji Umemura; Eiji Tanaka; Frank J Gonzalez; Shu-Ichi Ikeda; Toshifumi Aoyama
Journal:  Biochim Biophys Acta       Date:  2014-12-20

6.  Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet.

Authors:  Naoki Tanaka; Shogo Takahashi; Zhong-Ze Fang; Tsutomu Matsubara; Kristopher W Krausz; Aijuan Qu; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2014-08-29

7.  Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.

Authors:  Naoyuki Fujimori; Naoki Tanaka; Soichiro Shibata; Kenji Sano; Tomoo Yamazaki; Tomohiro Sekiguchi; Hiroyuki Kitabatake; Yuki Ichikawa; Takefumi Kimura; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Journal:  Hepatol Res       Date:  2016-03-15       Impact factor: 4.288

Review 8.  Glycerolipid metabolism and signaling in health and disease.

Authors:  Marc Prentki; S R Murthy Madiraju
Journal:  Endocr Rev       Date:  2008-07-07       Impact factor: 19.871

Review 9.  Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins.

Authors:  Sofie M A Walenbergh; Ger H Koek; Veerle Bieghs; Ronit Shiri-Sverdlov
Journal:  J Hepatol       Date:  2012-11-23       Impact factor: 25.083

10.  Gadd45 in stress signaling.

Authors:  Dan A Liebermann; Barbara Hoffman
Journal:  J Mol Signal       Date:  2008-09-12
View more
  9 in total

1.  Celastrol ameliorates acute liver injury through modulation of PPARα.

Authors:  Qi Zhao; Ping Tang; Ting Zhang; Jian-Feng Huang; Xue-Rong Xiao; Wei-Feng Zhu; Frank J Gonzalez; Fei Li
Journal:  Biochem Pharmacol       Date:  2020-05-26       Impact factor: 5.858

2.  Dietary Restriction Suppresses Steatosis-Associated Hepatic Tumorigenesis in Hepatitis C Virus Core Gene Transgenic Mice.

Authors:  Fangping Jia; Pan Diao; Xiaojing Wang; Xiao Hu; Takefumi Kimura; Makoto Nakamuta; Ibuki Nakamura; Saki Shirotori; Yoshiko Sato; Kyoji Moriya; Kazuhiko Koike; Frank J Gonzalez; Jun Nakayama; Toshifumi Aoyama; Naoki Tanaka
Journal:  Liver Cancer       Date:  2020-07-10       Impact factor: 11.740

3.  Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study.

Authors:  Yarong Yang; Zexin Huang; Zhao Yang; Ying Qi; Hui Shi; Yifei Zhou; Fangyu Wang; Miaofang Yang
Journal:  PeerJ       Date:  2021-05-03       Impact factor: 2.984

4.  Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.

Authors:  Naoyuki Fujimori; Takeji Umemura; Takefumi Kimura; Naoki Tanaka; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Yoko Usami; Kenji Sano; Koji Igarashi; Akihiro Matsumoto; Eiji Tanaka
Journal:  World J Gastroenterol       Date:  2018-03-21       Impact factor: 5.742

5.  Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.

Authors:  Yan Jiang; Chan Xiang; Fan Zhong; Yang Zhang; Liyan Wang; Yuanyuan Zhao; Jiucun Wang; Chen Ding; Li Jin; Fuchu He; Haijian Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 6.  The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease.

Authors:  Sylwia Ziolkowska; Agata Binienda; Maciej Jabłkowski; Janusz Szemraj; Piotr Czarny
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

7.  Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.

Authors:  Takefumi Kimura; Naoki Tanaka; Naoyuki Fujimori; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Journal:  World J Gastroenterol       Date:  2018-04-07       Impact factor: 5.742

8.  Prdx1 Reduces Intracerebral Hemorrhage-Induced Brain Injury via Targeting Inflammation- and Apoptosis-Related mRNA Stability.

Authors:  Guo-Qiang Yang; Jia-Cheng Huang; Jun-Jie Yuan; Qin Zhang; Chang-Xiong Gong; Qiong Chen; Qi Xie; Le-Xing Xie; Ru Chen; Zhong-Ming Qiu; Kai Zhou; Rui Xu; Guo-Hui Jiang; Xiao-Yi Xiong; Qing-Wu Yang
Journal:  Front Neurosci       Date:  2020-03-10       Impact factor: 4.677

9.  GADD45A is a protective modifier of neurogenic skeletal muscle atrophy.

Authors:  Jeffrey T Ehmsen; Riki Kawaguchi; Damlanur Kaval; Anna E Johnson; Daniel Nachun; Giovanni Coppola; Ahmet Höke
Journal:  JCI Insight       Date:  2021-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.